MwanzoSRT3 • ETR
add
Sartorius AG Preference Shares
Bei iliyotangulia
€ 227.10
Bei za siku
€ 227.80 - € 235.50
Bei za mwaka
€ 166.05 - € 299.40
Thamani ya kampuni katika soko
16.01B EUR
Wastani wa hisa zilizouzwa
elfu 150.02
Uwiano wa bei na mapato
168.59
Mgao wa faida
0.31%
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 883.00M | 7.74% |
Matumizi ya uendeshaji wa biashara | 293.50M | 7.23% |
Mapato halisi | 48.50M | 31.44% |
Kiwango cha faida halisi | 5.49 | 22.00% |
Mapato kwa kila hisa | 1.22 | 20.79% |
EBITDA | 241.00M | 10.55% |
Asilimia ya kodi ya mapato | 27.01% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 839.50M | -23.88% |
Jumla ya mali | 10.11B | -4.85% |
Jumla ya dhima | 6.27B | -8.65% |
Jumla ya hisa | 3.84B | — |
hisa zilizosalia | — | — |
Uwiano wa bei na thamani | — | — |
Faida inayotokana na mali | 3.40% | — |
Faida inayotokana mtaji | 4.06% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 48.50M | 31.44% |
Pesa kutokana na shughuli | 139.20M | 206.61% |
Pesa kutokana na uwekezaji | -78.00M | 42.35% |
Pesa kutokana na ufadhili | -34.10M | -104.20% |
Mabadiliko halisi ya pesa taslimu | 26.10M | -96.39% |
Mtiririko huru wa pesa | 21.24M | 118.21% |
Kuhusu
Sartorius AG is an international pharmaceutical and laboratory equipment supplier. In September 2021, Sartorius was admitted to the DAX, Germany's largest stock market index. Sartorius supports its customers in the development and production of biotech drugs and vaccines. The company has two major divisions: Bioprocess Solutions and Lab Products & Services. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1870
Tovuti
Wafanyakazi
13,573
